- Raised $3M Follow-on PO led by Haywood Securities Inc., Jun 2026
About
ALZAI Health Corp. is a healthcare technology company developing non-invasive, artificial intelligence-driven disease risk identification solutions using routine healthcare data. Its proprietary platform identifies individuals at elevated risk for disease before clinical diagnosis, enabling earlier intervention opportunities and supporting improved patient outcomes. ALZAI's technology has been validated on large-scale healthcare datasets and is designed for integration into existing healthcare infrastructure, including electronic medical record systems, cloud-based environments, and enterprise healthcare platforms. The company's mission is to address a critical gap in the fight against Alzheimer's Disease by delivering effective risk screening for better detection, earlier treatment, and effective prevention. ALZAI also secured an exclusive global license for AI-driven liver disease risk identification technology, expanding its platform beyond Alzheimer's disease.
Funding history · 1 round · $3.0M total
Offices
Q&A
- What is ALZAI Health's primary focus?
- ALZAI Health focuses on developing non-invasive, AI-driven disease risk identification solutions using routine healthcare data, primarily for Alzheimer's Disease.
- When was ALZAI Health founded?
- ALZAI Health was founded in 2024.
- What is ALZAI Health's primary sector?
- ALZAI Health's primary sector is HealthTech.
- Where is ALZAI Health headquartered?
- ALZAI Health is headquartered in Toronto, Canada.
- What is ALZAI Health's mission regarding Alzheimer's Disease?
- ALZAI Health's mission is to address a critical gap in the fight against Alzheimer's Disease by delivering effective risk screening for better detection, earlier treatment, and effective prevention.
- What other disease area has ALZAI Health expanded into?
- ALZAI Health has secured an exclusive global license for AI-driven liver disease risk identification technology, expanding its platform beyond Alzheimer's disease.
- Who are the co-founders of ALZAI Health?
- The co-founders of ALZAI Health are Hayim Raclaw (CEO), Roy Kait (CRO), Dr. Amir Glik (CMO), and Ofri Kait (Director Business Development & Operations).
- When did ALZAI Health conduct an IPO and how much capital was raised?
- In June 2026, ALZAI Health conducted an IPO, raising $2,956,500. Haywood Securities Inc. was a lead investor in this round.
Team · 7
Sectors & technology
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
External links
| Website | alzaihealth.com |
|---|
Identifiers & details
| Legal name | ALZAI Health Corp. |
|---|---|
| Founded | 2024 |
Radar intelligence
Web history (Wayback)
| Domain | alzaihealth.com |
|---|
Israeli Companies Registrar (רשם החברות / ICA)
| Registrar # (ח.פ.) | 517079745 |
|---|---|
| Status | פעילה |
| Corp type | ישראלית חברה פרטית |
| Incorporated | 2024-12-15 |
| Purpose | לעסוק בכל עיסוק חוקי |
| Liability | מוגבלת |
| In violation (unfiled) | no |
| Last annual report | 2025 |
| Active charges / liens | 0 |
| Registry events | 4 — other (1), annual_report (2), people (1) |
| Registered address | אריאל שרון 4 גבעתיים |
Recent registry events
| Date | Event |
|---|---|
| 2026-01-25 | עדכון כתובת ו/או מען דיגיטלי |
| 2025-12-11 | דו~ח שנתי-שינוי בהוראות בתקנון |
| 2025-12-11 | דו~ח שנתי-הוספת בעל תפקיד |
| 2026-06-07 | עדכון דירקטורים-הוספת דירקטור |